サイクリン依存性キナーゼ6 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "サイクリン依存性キナーゼ6" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

5^th place

19^th place

1,626^th place

2,625^th place

low place

low place

doi.org

“A family of human cdc2-related protein kinases”. The EMBO Journal 11 (8): 2909–17. (Aug 1992). doi:10.1002/j.1460-2075.1992.tb05360.x. PMC 556772. PMID 1639063.
Meyerson, M; Harlow, E (1994). “Identification of G1 Kinase Activity for cdk6, a Novel Cyclin D Partner”. Molecular and Cellular Biology 14 (3): 2077–86. doi:10.1128/MCB.14.3.2077. PMC 358568. PMID 8114739.
“Cdks, cyclins and CKIs: roles beyond cell cycle regulation”. Development 140 (15): 3079–93. (Aug 2013). doi:10.1242/dev.091744. PMID 23861057.
Liu, Ji; Kipreos, Edward T. (2000). “Evolution of Cyclin-Dependent Kinases (CDKs) and CDK-Activating Kinases (CAKs): Differential Conservation of CAKs in Yeast and Metazoa”. Molecular Biology and Evolution 17 (7): 1061–74. doi:10.1093/oxfordjournals.molbev.a026387. PMID 10889219.
“Control of cell cycle transcription during G1 and S phases”. Nature Reviews Molecular Cell Biology 14 (8): 518–28. (Aug 2013). doi:10.1038/nrm3629. PMC 4569015. PMID 23877564.
“Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo”. Molecular and Cellular Biology 21 (14): 4773–84. (Jul 2001). doi:10.1128/MCB.21.14.4773-4784.2001. PMC 87164. PMID 11416152.
“Beyond the cell cycle: a new role for Cdk6 in differentiation”. Journal of Cellular Biochemistry 97 (3): 485–93. (Feb 2006). doi:10.1002/jcb.20712. PMID 16294322.
Bartek, J; Lukas, J (2001). “Mammalian G1- and S-Phase Checkpoints in Response to DNA Damage”. Current Opinion in Cell Biology 13 (6): 738–47. doi:10.1016/s0955-0674(00)00280-5. PMID 11698191.
Kozar, Katarzyna; Sicinski, Piotr (2005-03). “Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes”. Cell Cycle (Georgetown, Tex.) 4 (3): 388–391. doi:10.4161/cc.4.3.1551. ISSN 1551-4005. PMID 15738651.
“Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6”. Cell 118 (4): 493–504. (Aug 2004). doi:10.1016/j.cell.2004.08.002. PMID 15315761.
Grossel, Martha J.; Hinds, Philip W. (2006-02). “From cell cycle to differentiation: an expanding role for cdk6”. Cell Cycle (Georgetown, Tex.) 5 (3): 266–270. doi:10.4161/cc.5.3.2385. ISSN 1551-4005. PMID 16410727.
“Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6)”. Oncogene 20 (23): 2889–99. (May 2001). doi:10.1038/sj.onc.1204396. PMID 11420701.
“Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle”. Metabolomics 8 (3): 454–64. (Jun 2012). doi:10.1007/s11306-011-0328-x. PMC 3361763. PMID 22661920.
Hussain, Muhammad S (2013). “CDK6 Associates with the Centrosome during Mitosis and Is Mutated in a Large Pakistani Family with Primary Microcephaly”. Human Molecular Genetics 22 (25): 5199–5214. doi:10.1093/hmg/ddt374. PMID 23918663.
“Targeting cell cycle regulation in cancer therapy”. Pharmacology & Therapeutics 138 (2): 255–71. (May 2013). doi:10.1016/j.pharmthera.2013.01.011. PMID 23356980.
LaBaer, J (1997). “New Functional Activities for the p21 Family of CDK Inhibitors”. Genes & Development 11 (7): 847–62. doi:10.1101/gad.11.7.847. PMID 9106657.
“The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity”. The Journal of Biological Chemistry 280 (12): 11165–74. (Mar 2005). doi:10.1074/jbc.M408887200. PMID 15664993.
Nurse, P (2000). “A Long Twentieth Century of the Cell Cycle and beyond”. Cell 100 (1): 71–78. doi:10.1016/s0092-8674(00)81684-0. PMID 10647932.
“Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors"”. Molecular and Cellular Biology 26 (13): 5070–85. (Jul 2006). doi:10.1128/MCB.02006-05. PMC 1489149. PMID 16782892.
“A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis”. Cancer Cell 24 (2): 167–81. (Aug 2013). doi:10.1016/j.ccr.2013.07.012. PMC 3743049. PMID 23948297.
Khleif, S N (1996). “Inhibition of Cyclin D-CDK4/CDK6 Activity Is Associated with an E2F-Mediated Induction of Cyclin Kinase Inhibitor Activity”. Proceedings of the National Academy of Sciences of the United States of America 93 (9): 4350–54. doi:10.1073/pnas.93.9.4350. PMC 39540. PMID 8633069.
“Tumour selective targeting of cell cycle kinases for cancer treatment”. Current Opinion in Pharmacology 13 (4): 529–35. (Aug 2013). doi:10.1016/j.coph.2013.03.012. PMID 23597425.
“Knockdown of CDK6 enhances glioma sensitivity to chemotherapy”. Oncology Reports 28 (3): 909–14. (Sep 2012). doi:10.3892/or.2012.1884. PMID 22736304.
“Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex”. British Journal of Cancer 109 (10): 2751–62. (Nov 2013). doi:10.1038/bjc.2013.583. PMC 3833203. PMID 24169358.
“Genomic instability--an evolving hallmark of cancer”. Nature Reviews Molecular Cell Biology 11 (3): 220–28. (Mar 2010). doi:10.1038/nrm2858. PMID 20177397.
“Expression of miR-124 inhibits growth of medulloblastoma cells”. Neuro-Oncology 15 (1): 83–90. (Jan 2013). doi:10.1093/neuonc/nos281. PMC 3534424. PMID 23172372.
“Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis”. Cancer Cell 9 (1): 13–22. (Jan 2006). doi:10.1016/j.ccr.2005.12.019. PMID 16413468.
“Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology 3: 89. (2007). doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
“Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function”. Genes & Development 8 (24): 2939–52. (Dec 1994). doi:10.1101/gad.8.24.2939. PMID 8001816.
“Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors”. Genes & Development 14 (24): 3115–25. (Dec 2000). doi:10.1101/gad.851100. PMC 317144. PMID 11124804.
“Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence”. Oncogene 20 (16): 2000–9. (Apr 2001). doi:10.1038/sj.onc.1204375. PMID 11360184.
“Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)”. Genes & Development 13 (22): 3027–33. (Nov 1999). doi:10.1101/gad.13.22.3027. PMC 317153. PMID 10580009.
“Identification of G1 kinase activity for cdk6, a novel cyclin D partner”. Molecular and Cellular Biology 14 (3): 2077–86. (Mar 1994). doi:10.1128/MCB.14.3.2077. PMC 358568. PMID 8114739.
“Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A”. Current Biology 6 (1): 84–91. (Jan 1996). doi:10.1016/s0960-9822(02)00425-6. PMID 8805225.
“Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a”. Nature 395 (6699): 237–43. (Sep 1998). doi:10.1038/26155. PMID 9751050.
“CAK-independent activation of CDK6 by a viral cyclin”. Molecular Biology of the Cell 12 (12): 3987–99. (Dec 2001). doi:10.1091/mbc.12.12.3987. PMC 60770. PMID 11739795.
“Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms”. The Journal of Biological Chemistry 275 (44): 34744–9. (Nov 2000). doi:10.1074/jbc.M006210200. PMID 10934208.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000105810 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000040274 - Ensembl, May 2017

nih.gov

pubmed.ncbi.nlm.nih.gov

“A family of human cdc2-related protein kinases”. The EMBO Journal 11 (8): 2909–17. (Aug 1992). doi:10.1002/j.1460-2075.1992.tb05360.x. PMC 556772. PMID 1639063.
Meyerson, M; Harlow, E (1994). “Identification of G1 Kinase Activity for cdk6, a Novel Cyclin D Partner”. Molecular and Cellular Biology 14 (3): 2077–86. doi:10.1128/MCB.14.3.2077. PMC 358568. PMID 8114739.
“Cdks, cyclins and CKIs: roles beyond cell cycle regulation”. Development 140 (15): 3079–93. (Aug 2013). doi:10.1242/dev.091744. PMID 23861057.
Liu, Ji; Kipreos, Edward T. (2000). “Evolution of Cyclin-Dependent Kinases (CDKs) and CDK-Activating Kinases (CAKs): Differential Conservation of CAKs in Yeast and Metazoa”. Molecular Biology and Evolution 17 (7): 1061–74. doi:10.1093/oxfordjournals.molbev.a026387. PMID 10889219.
“Control of cell cycle transcription during G1 and S phases”. Nature Reviews Molecular Cell Biology 14 (8): 518–28. (Aug 2013). doi:10.1038/nrm3629. PMC 4569015. PMID 23877564.
“Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo”. Molecular and Cellular Biology 21 (14): 4773–84. (Jul 2001). doi:10.1128/MCB.21.14.4773-4784.2001. PMC 87164. PMID 11416152.
“Beyond the cell cycle: a new role for Cdk6 in differentiation”. Journal of Cellular Biochemistry 97 (3): 485–93. (Feb 2006). doi:10.1002/jcb.20712. PMID 16294322.
Bartek, J; Lukas, J (2001). “Mammalian G1- and S-Phase Checkpoints in Response to DNA Damage”. Current Opinion in Cell Biology 13 (6): 738–47. doi:10.1016/s0955-0674(00)00280-5. PMID 11698191.
Kozar, Katarzyna; Sicinski, Piotr (2005-03). “Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes”. Cell Cycle (Georgetown, Tex.) 4 (3): 388–391. doi:10.4161/cc.4.3.1551. ISSN 1551-4005. PMID 15738651.
“Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6”. Cell 118 (4): 493–504. (Aug 2004). doi:10.1016/j.cell.2004.08.002. PMID 15315761.
Grossel, Martha J.; Hinds, Philip W. (2006-02). “From cell cycle to differentiation: an expanding role for cdk6”. Cell Cycle (Georgetown, Tex.) 5 (3): 266–270. doi:10.4161/cc.5.3.2385. ISSN 1551-4005. PMID 16410727.
Ericson, Karen K.; Krull, David; Slomiany, Peter; Grossel, Martha J. (2003-07). “Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes”. Molecular cancer research: MCR 1 (9): 654–664. ISSN 1541-7786. PMID 12861051.
“Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6)”. Oncogene 20 (23): 2889–99. (May 2001). doi:10.1038/sj.onc.1204396. PMID 11420701.
“Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle”. Metabolomics 8 (3): 454–64. (Jun 2012). doi:10.1007/s11306-011-0328-x. PMC 3361763. PMID 22661920.
Hussain, Muhammad S (2013). “CDK6 Associates with the Centrosome during Mitosis and Is Mutated in a Large Pakistani Family with Primary Microcephaly”. Human Molecular Genetics 22 (25): 5199–5214. doi:10.1093/hmg/ddt374. PMID 23918663.
“Targeting cell cycle regulation in cancer therapy”. Pharmacology & Therapeutics 138 (2): 255–71. (May 2013). doi:10.1016/j.pharmthera.2013.01.011. PMID 23356980.
LaBaer, J (1997). “New Functional Activities for the p21 Family of CDK Inhibitors”. Genes & Development 11 (7): 847–62. doi:10.1101/gad.11.7.847. PMID 9106657.
“The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity”. The Journal of Biological Chemistry 280 (12): 11165–74. (Mar 2005). doi:10.1074/jbc.M408887200. PMID 15664993.
Nurse, P (2000). “A Long Twentieth Century of the Cell Cycle and beyond”. Cell 100 (1): 71–78. doi:10.1016/s0092-8674(00)81684-0. PMID 10647932.
“Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors"”. Molecular and Cellular Biology 26 (13): 5070–85. (Jul 2006). doi:10.1128/MCB.02006-05. PMC 1489149. PMID 16782892.
“A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis”. Cancer Cell 24 (2): 167–81. (Aug 2013). doi:10.1016/j.ccr.2013.07.012. PMC 3743049. PMID 23948297.
Khleif, S N (1996). “Inhibition of Cyclin D-CDK4/CDK6 Activity Is Associated with an E2F-Mediated Induction of Cyclin Kinase Inhibitor Activity”. Proceedings of the National Academy of Sciences of the United States of America 93 (9): 4350–54. doi:10.1073/pnas.93.9.4350. PMC 39540. PMID 8633069.
“Tumour selective targeting of cell cycle kinases for cancer treatment”. Current Opinion in Pharmacology 13 (4): 529–35. (Aug 2013). doi:10.1016/j.coph.2013.03.012. PMID 23597425.
“Knockdown of CDK6 enhances glioma sensitivity to chemotherapy”. Oncology Reports 28 (3): 909–14. (Sep 2012). doi:10.3892/or.2012.1884. PMID 22736304.
“Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex”. British Journal of Cancer 109 (10): 2751–62. (Nov 2013). doi:10.1038/bjc.2013.583. PMC 3833203. PMID 24169358.
“Genomic instability--an evolving hallmark of cancer”. Nature Reviews Molecular Cell Biology 11 (3): 220–28. (Mar 2010). doi:10.1038/nrm2858. PMID 20177397.
“Expression of miR-124 inhibits growth of medulloblastoma cells”. Neuro-Oncology 15 (1): 83–90. (Jan 2013). doi:10.1093/neuonc/nos281. PMC 3534424. PMID 23172372.
“Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis”. Cancer Cell 9 (1): 13–22. (Jan 2006). doi:10.1016/j.ccr.2005.12.019. PMID 16413468.
“Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology 3: 89. (2007). doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
“Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function”. Genes & Development 8 (24): 2939–52. (Dec 1994). doi:10.1101/gad.8.24.2939. PMID 8001816.
“Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors”. Genes & Development 14 (24): 3115–25. (Dec 2000). doi:10.1101/gad.851100. PMC 317144. PMID 11124804.
“Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence”. Oncogene 20 (16): 2000–9. (Apr 2001). doi:10.1038/sj.onc.1204375. PMID 11360184.
“Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)”. Genes & Development 13 (22): 3027–33. (Nov 1999). doi:10.1101/gad.13.22.3027. PMC 317153. PMID 10580009.
“Identification of G1 kinase activity for cdk6, a novel cyclin D partner”. Molecular and Cellular Biology 14 (3): 2077–86. (Mar 1994). doi:10.1128/MCB.14.3.2077. PMC 358568. PMID 8114739.
“Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A”. Current Biology 6 (1): 84–91. (Jan 1996). doi:10.1016/s0960-9822(02)00425-6. PMID 8805225.
“Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a”. Nature 395 (6699): 237–43. (Sep 1998). doi:10.1038/26155. PMID 9751050.
“CAK-independent activation of CDK6 by a viral cyclin”. Molecular Biology of the Cell 12 (12): 3987–99. (Dec 2001). doi:10.1091/mbc.12.12.3987. PMC 60770. PMID 11739795.
“Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms”. The Journal of Biological Chemistry 275 (44): 34744–9. (Nov 2000). doi:10.1074/jbc.M006210200. PMID 10934208.

ncbi.nlm.nih.gov

Human PubMed Reference:
Mouse PubMed Reference:
“A family of human cdc2-related protein kinases”. The EMBO Journal 11 (8): 2909–17. (Aug 1992). doi:10.1002/j.1460-2075.1992.tb05360.x. PMC 556772. PMID 1639063.
“Entrez Gene: CDK6 cyclin-dependent kinase 6”. 2020年1月18日閲覧。
Meyerson, M; Harlow, E (1994). “Identification of G1 Kinase Activity for cdk6, a Novel Cyclin D Partner”. Molecular and Cellular Biology 14 (3): 2077–86. doi:10.1128/MCB.14.3.2077. PMC 358568. PMID 8114739.
Harvey Lodish et al., Molecular Cell Biology. 4th Edition., 2000, https://www.ncbi.nlm.nih.gov/books/NBK21497/.
“Control of cell cycle transcription during G1 and S phases”. Nature Reviews Molecular Cell Biology 14 (8): 518–28. (Aug 2013). doi:10.1038/nrm3629. PMC 4569015. PMID 23877564.
“Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo”. Molecular and Cellular Biology 21 (14): 4773–84. (Jul 2001). doi:10.1128/MCB.21.14.4773-4784.2001. PMC 87164. PMID 11416152.
Kozar, Katarzyna; Sicinski, Piotr (2005-03). “Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes”. Cell Cycle (Georgetown, Tex.) 4 (3): 388–391. doi:10.4161/cc.4.3.1551. ISSN 1551-4005. PMID 15738651.
Grossel, Martha J.; Hinds, Philip W. (2006-02). “From cell cycle to differentiation: an expanding role for cdk6”. Cell Cycle (Georgetown, Tex.) 5 (3): 266–270. doi:10.4161/cc.5.3.2385. ISSN 1551-4005. PMID 16410727.
Ericson, Karen K.; Krull, David; Slomiany, Peter; Grossel, Martha J. (2003-07). “Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes”. Molecular cancer research: MCR 1 (9): 654–664. ISSN 1541-7786. PMID 12861051.
“Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle”. Metabolomics 8 (3): 454–64. (Jun 2012). doi:10.1007/s11306-011-0328-x. PMC 3361763. PMID 22661920.
“Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors"”. Molecular and Cellular Biology 26 (13): 5070–85. (Jul 2006). doi:10.1128/MCB.02006-05. PMC 1489149. PMID 16782892.
“A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis”. Cancer Cell 24 (2): 167–81. (Aug 2013). doi:10.1016/j.ccr.2013.07.012. PMC 3743049. PMID 23948297.
Khleif, S N (1996). “Inhibition of Cyclin D-CDK4/CDK6 Activity Is Associated with an E2F-Mediated Induction of Cyclin Kinase Inhibitor Activity”. Proceedings of the National Academy of Sciences of the United States of America 93 (9): 4350–54. doi:10.1073/pnas.93.9.4350. PMC 39540. PMID 8633069.
“Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex”. British Journal of Cancer 109 (10): 2751–62. (Nov 2013). doi:10.1038/bjc.2013.583. PMC 3833203. PMID 24169358.
“Expression of miR-124 inhibits growth of medulloblastoma cells”. Neuro-Oncology 15 (1): 83–90. (Jan 2013). doi:10.1093/neuonc/nos281. PMC 3534424. PMID 23172372.
“Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology 3: 89. (2007). doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
“Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors”. Genes & Development 14 (24): 3115–25. (Dec 2000). doi:10.1101/gad.851100. PMC 317144. PMID 11124804.
“Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)”. Genes & Development 13 (22): 3027–33. (Nov 1999). doi:10.1101/gad.13.22.3027. PMC 317153. PMID 10580009.
“Identification of G1 kinase activity for cdk6, a novel cyclin D partner”. Molecular and Cellular Biology 14 (3): 2077–86. (Mar 1994). doi:10.1128/MCB.14.3.2077. PMC 358568. PMID 8114739.
“CAK-independent activation of CDK6 by a viral cyclin”. Molecular Biology of the Cell 12 (12): 3987–99. (Dec 2001). doi:10.1091/mbc.12.12.3987. PMC 60770. PMID 11739795.

pmc.ncbi.nlm.nih.gov

wikipedia.org

en.wikipedia.org

GRCh38: Ensembl release 89: ENSG00000105810 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000040274 - Ensembl, May 2017

worldcat.org

search.worldcat.org

Kozar, Katarzyna; Sicinski, Piotr (2005-03). “Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes”. Cell Cycle (Georgetown, Tex.) 4 (3): 388–391. doi:10.4161/cc.4.3.1551. ISSN 1551-4005. PMID 15738651.
Grossel, Martha J.; Hinds, Philip W. (2006-02). “From cell cycle to differentiation: an expanding role for cdk6”. Cell Cycle (Georgetown, Tex.) 5 (3): 266–270. doi:10.4161/cc.5.3.2385. ISSN 1551-4005. PMID 16410727.
Ericson, Karen K.; Krull, David; Slomiany, Peter; Grossel, Martha J. (2003-07). “Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes”. Molecular cancer research: MCR 1 (9): 654–664. ISSN 1541-7786. PMID 12861051.